Source author record

Patricia J Kissinger

Patricia J Kissinger appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

1works
1topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

1 published item(s)

preprint2021arXiv

Modelling the Impact of Screening Men for Chlamydia Trachomatis on the Prevalence in Women

Chlamydia trachomatis is the most commonly reported infectious disease in the United States and causes important reproductive morbidity in women. The Centers for Disease Control and Prevention have recommended routine screening of sexually active women under age 25 but have not recommended screening among men. Consequently, untested and untreated men may serve as a reservoir of infection in women. Despite three decades of screening women, the chlamydia prevalence has continued to increase. Moreover, chlamydia is five times more common in African American (AA) youth compared to Whites, constituting an important health disparity. The Check It program is a bundled Ct intervention targeting AA men aged 15-24 who have sex with women. We created an individual-based network model to simulate a realistic chlamydia epidemic on sexual contact networks for the target population. Based on the practice in Check It, we quantified the impact of screening young AA men on the chlamydia prevalence in women. We used sensitivity analysis to quantify the relative importance of each Check It intervention component, and the significance ranked from high to low was venue-based screening, expedited index treatment, expedited partner treatment, rescreening. We estimated that by annually screening 7.5% of the target male population, the chlamydia prevalence would be reduced by 8.1% and 8.8% in men and women, respectively. The findings suggested that male-screening has the potential to significantly reduce the prevalence among women.